199 related articles for article (PubMed ID: 1590690)
1. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.
Coates JA; Cammack N; Jenkinson HJ; Mutton IM; Pearson BA; Storer R; Cameron JM; Penn CR
Antimicrob Agents Chemother; 1992 Jan; 36(1):202-5. PubMed ID: 1590690
[TBL] [Abstract][Full Text] [Related]
2. Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog.
Soudeyns H; Yao XI; Gao Q; Belleau B; Kraus JL; Nguyen-Ba N; Spira B; Wainberg MA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1386-90. PubMed ID: 1929298
[TBL] [Abstract][Full Text] [Related]
3. (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.
Coates JA; Cammack N; Jenkinson HJ; Jowett AJ; Jowett MI; Pearson BA; Penn CR; Rouse PL; Viner KC; Cameron JM
Antimicrob Agents Chemother; 1992 Apr; 36(4):733-9. PubMed ID: 1380229
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
Schinazi RF; McMillan A; Cannon D; Mathis R; Lloyd RM; Peck A; Sommadossi JP; St Clair M; Wilson J; Furman PA
Antimicrob Agents Chemother; 1992 Nov; 36(11):2423-31. PubMed ID: 1283296
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
[TBL] [Abstract][Full Text] [Related]
6. Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs.
Rooke R; Parniak MA; Tremblay M; Soudeyns H; Li XG; Gao Q; Yao XJ; Wainberg MA
Antimicrob Agents Chemother; 1991 May; 35(5):988-91. PubMed ID: 1649576
[TBL] [Abstract][Full Text] [Related]
7. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
[TBL] [Abstract][Full Text] [Related]
8. High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.
Boucher CA; Cammack N; Schipper P; Schuurman R; Rouse P; Wainberg MA; Cameron JM
Antimicrob Agents Chemother; 1993 Oct; 37(10):2231-4. PubMed ID: 7504909
[TBL] [Abstract][Full Text] [Related]
9. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
Gao Q; Gu Z; Hiscott J; Dionne G; Wainberg MA
Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.
Schinazi RF; Lloyd RM; Nguyen MH; Cannon DL; McMillan A; Ilksoy N; Chu CK; Liotta DC; Bazmi HZ; Mellors JW
Antimicrob Agents Chemother; 1993 Apr; 37(4):875-81. PubMed ID: 7684216
[TBL] [Abstract][Full Text] [Related]
11. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine.
Gao Q; Gu Z; Parniak MA; Cameron J; Cammack N; Boucher C; Wainberg MA
Antimicrob Agents Chemother; 1993 Jun; 37(6):1390-2. PubMed ID: 8392313
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.
Blaney SM; Daniel MJ; Harker AJ; Godwin K; Balis FM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2779-82. PubMed ID: 8593019
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL
J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429
[TBL] [Abstract][Full Text] [Related]
15. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
Shewach DS; Liotta DC; Schinazi RF
Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
[TBL] [Abstract][Full Text] [Related]
16. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, lamivudine): a potent anti-HIV agent.
Mahmoudian M; Baines BS; Drake CS; Hale RS; Jones P; Piercey JE; Montgomery DS; Purvis IJ; Storer R; Dawson MJ
Enzyme Microb Technol; 1993 Sep; 15(9):749-55. PubMed ID: 7764073
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of oxaselenolane nucleosides.
Chu CK; Ma L; Olgen S; Pierra C; Du J; Gumina G; Gullen E; Cheng YC; Schinazi RF
J Med Chem; 2000 Oct; 43(21):3906-12. PubMed ID: 11052795
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.
Stoddart CA; Moreno ME; Linquist-Stepps VD; Bare C; Bogan MR; Gobbi A; Buckheit RW; Bedard J; Rando RF; McCune JM
Antimicrob Agents Chemother; 2000 Mar; 44(3):783-6. PubMed ID: 10681360
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and enantioselectivity of the antiviral effects of (R,Z)-,(S,Z)-methylenecyclopropane analogues of purine nucleosides and phosphoralaninate prodrugs: influence of heterocyclic base, type of virus and host cells.
Qiu YL; Geiser F; Kira T; Gullen E; Cheng YC; Ptak RG; Breitenbach JM; Drach JC; Hartline CB; Kern ER; Zemlicka J
Antivir Chem Chemother; 2000 May; 11(3):191-202. PubMed ID: 10901290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
